Mankind Pharma 
Business

Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,630 crore

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

PTI

NEW DELHI: Mankind Pharma on Thursday said it will fully acquire Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

This strategic move marks a significant leap for the drug maker, positioning it as a leader in the Indian women's health and fertility drug market, alongside access to other high entry barrier products in critical care with established complex R&D tech platforms, it added. 

Also Read

TN raises monthly contingency funds for police stations to reduce corrupt practices

Return of people after holidays to Chennai triggers traffic congestion near Kilambakkam bus terminus

HIGHLIGHTS | Tamil Nadu rains: Schools closed in 5 districts, including Chennai, as twin low-pressure areas loom

Delhi HC to urgently hear pleas by CJP's Saurav Das, Ashutosh Ranka, AISA's Neha Bora

SBI data breach: PSU bank confirms 3,897 customer records exposed on dark web

SCROLL FOR NEXT